Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.

Chief Strategist, Health Practice, Edelman

Our most popular articles of the year offered our predictions on disruption and the future market, and highlighted our views on healthcare reform, ACOs, and much more.

Seeing a return on investment in pharma marketing means understanding what happens to every dollar.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Digital & Analytics, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Purposeful collaboration will help more people understand how their daily decisions dictate their health.

Director, Oliver Wyman Health Innovation Center, Oliver Wyman

How pharmaceutical companies can better define, measure, and deliver value to patients.

Director, Marsh & McLennan Advantage, Healthcare
Former Engagement Manager, Oliver Wyman

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Global Leader, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More